Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05672680 · ClinicalTrials.gov registry record · Phase 2
Transabdominal Plane (TAP) Blocks for Inguinal Hernia Repairs
A Phase 2 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT05672680 is a Phase 2 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants.
The verdict
NCT05672680, a Phase 2 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The aim of this double-blind clinical trial is to examine outcomes and pain control after surgery in patients who underwent laparoscopic inguinal hernia repair (IHR) with the use of perioperative transabdominal plane (TAP) block. Research Question: Does transabdominal plane block improve pain when undergoing inguinal hernia repair? The endpoints include whether preoperative TAP blocks improve pain score (primary end point) and decrease opioid use (secondary endpoint) after an inguinal hernia repair. Other end points- complications after surgery.
Interventions
- DRUG Placebo
- DRUG 0.25% Bupivacaine
- PROCEDURE TAP block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-12-09 |
| Est. Completion | 2023-08-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05672680
The ClinicalTrials.gov registry entry for NCT05672680 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT05672680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05672680 about?
NCT05672680 is a clinical study titled "Transabdominal Plane (TAP) Blocks for Inguinal Hernia Repairs". The aim of this double-blind clinical trial is to examine outcomes and pain control after surgery in patients who underwent laparoscopic inguinal hernia repair (IHR) with the use of perioperative transabdominal plane (TAP) block. Research Question: Does transabdominal plane block improve pain when ...
What is the current status of trial NCT05672680?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2019-12-09. Estimated completion is 2023-08-03.
What interventions are being tested in trial NCT05672680?
The interventions under investigation include: Placebo (DRUG), 0.25% Bupivacaine (DRUG), TAP block (PROCEDURE).
Who is sponsoring clinical trial NCT05672680?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.